D R Jayne

Summary

Affiliation: St George's Hospital Medical School
Country: UK

Publications

  1. ncbi Update on the European Vasculitis Study Group trials
    D Jayne
    Senior Lecturer in Renal Medicine, Renal Unit, St Helier Hospital, Carshalton, Surrey, UK
    Curr Opin Rheumatol 13:48-55. 2001
  2. ncbi Immunotherapy for autoimmune and inflammatory renal diseases
    D R Jayne
    Division of Renal Medicine, St George s Hospital Medical School, London, UK
    Curr Opin Nephrol Hypertens 7:311-5. 1998
  3. ncbi Non-transplant uses of mycophenolate mofetil
    D Jayne
    Division of Renal Medicine, St George s Hospital Medical School, London, UK
    Curr Opin Nephrol Hypertens 8:563-7. 1999
  4. ncbi Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity
    D R Jayne
    Division of Renal Medicine, St George s Hospital Medical School and Renal Unit, St Helier Hospital, London
    QJM 93:433-9. 2000
  5. ncbi Autoantibodies to endothelial cells and neutrophil cytoplasmic antigens in systemic vasculitis
    G Frampton
    Renal Unit, United Medical and Dental School, London, England
    Clin Exp Immunol 82:227-32. 1990

Collaborators

Detail Information

Publications5

  1. ncbi Update on the European Vasculitis Study Group trials
    D Jayne
    Senior Lecturer in Renal Medicine, Renal Unit, St Helier Hospital, Carshalton, Surrey, UK
    Curr Opin Rheumatol 13:48-55. 2001
    ..The established infrastructure and accumulated database are well placed to facilitate testing of newer therapeutic strategies in the future...
  2. ncbi Immunotherapy for autoimmune and inflammatory renal diseases
    D R Jayne
    Division of Renal Medicine, St George s Hospital Medical School, London, UK
    Curr Opin Nephrol Hypertens 7:311-5. 1998
    ....
  3. ncbi Non-transplant uses of mycophenolate mofetil
    D Jayne
    Division of Renal Medicine, St George s Hospital Medical School, London, UK
    Curr Opin Nephrol Hypertens 8:563-7. 1999
    ..As yet, clinical experience with mycophenolate mofetil remains anecdotal but provides a strong platform for the scientific evaluation of mycophenolate mofetil as a new therapeutic agent for these conditions in the future...
  4. ncbi Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity
    D R Jayne
    Division of Renal Medicine, St George s Hospital Medical School and Renal Unit, St Helier Hospital, London
    QJM 93:433-9. 2000
    ..IVIg is an alternative treatment for AASV with persistent disease activity after standard therapy...
  5. ncbi Autoantibodies to endothelial cells and neutrophil cytoplasmic antigens in systemic vasculitis
    G Frampton
    Renal Unit, United Medical and Dental School, London, England
    Clin Exp Immunol 82:227-32. 1990
    ..Some patients with systemic vasculitis have detectable AECA that recognize different epitopes to ANCA and like ANCA, their titre correlates with disease activity and thus they may have a pathogenetic role in these conditions...